AAAAAA

   
Results: 1-25 | 26-46
Results: 1-25/46
COLLECTION OF MORE HEMATOPOIETIC PROGENITOR CELLS WITH LARGE-VOLUME LEUKAPHERESIS IN PATIENTS WITH MULTIPLE-MYELOMA
Authors: DESIKAN KR JAGANNATH S SIEGEL D NELSON J BRACY D BARLOGIE B TRICOT G
Citation: Kr. Desikan et al., COLLECTION OF MORE HEMATOPOIETIC PROGENITOR CELLS WITH LARGE-VOLUME LEUKAPHERESIS IN PATIENTS WITH MULTIPLE-MYELOMA, Leukemia & lymphoma, 28(5-6), 1998, pp. 501-508
COMPARABLE ENGRAFTMENT KINETICS FOLLOWING PERIPHERAL-BLOOD STEM-CELL INFUSION MOBILIZED WITH GRANULOCYTE-COLONY-STIMULATING FACTOR WITH OR WITHOUT CYCLOPHOSPHAMIDE IN MULTIPLE-MYELOMA
Authors: DESIKAN KR BARLOGIE B JAGANNATH S VESOLE DH SIEGEL D FASSAS A MUNSHI N SINGHAL S MEHTA J TINDLE S NELSON J BRACY D MATTOX S TRICOT G
Citation: Kr. Desikan et al., COMPARABLE ENGRAFTMENT KINETICS FOLLOWING PERIPHERAL-BLOOD STEM-CELL INFUSION MOBILIZED WITH GRANULOCYTE-COLONY-STIMULATING FACTOR WITH OR WITHOUT CYCLOPHOSPHAMIDE IN MULTIPLE-MYELOMA, Journal of clinical oncology, 16(4), 1998, pp. 1547-1553
DOUBLE AUTOTRANSPLANTS (DAT) FOR 542 PATIENTS WITH MULTIPLE-MYELOMA (MM)
Authors: BARLOGIE B TRICOT G DESIKAN KR SIEGEL D MEHTA J SINGHAL S JAGANNATH S
Citation: B. Barlogie et al., DOUBLE AUTOTRANSPLANTS (DAT) FOR 542 PATIENTS WITH MULTIPLE-MYELOMA (MM), Bone marrow transplantation, 22, 1998, pp. 5-5
MACLAFUNGIN, A NEW ANTIFUNGAL MACROCYCLIC LACTONE FROM ACTINOMYCETE SP.Y-8521050
Authors: MUKHOPADHYAY T NADKARNI SR PATEL MV BHAT RG DESIKAN KR GANGULI BN RUPP RH
Citation: T. Mukhopadhyay et al., MACLAFUNGIN, A NEW ANTIFUNGAL MACROCYCLIC LACTONE FROM ACTINOMYCETE SP.Y-8521050, Tetrahedron, 54(44), 1998, pp. 13621-13628
ANTI-MYELOMA ACTIVITY OF PAMIDRONATE IN-VIVO
Authors: DHODAPKAR MV SINGH J MEHTA J FASSAS A DESIKAN KR PERLMAN M MUNSHI NC BARLOGIE B
Citation: Mv. Dhodapkar et al., ANTI-MYELOMA ACTIVITY OF PAMIDRONATE IN-VIVO, British Journal of Haematology, 103(2), 1998, pp. 530-532
IDENTIFICATION OF NEW NONRANDOM TRANSLOCATIONS IN MULTIPLE-MYELOMA WITH MULTICOLOR SPECTRAL KARYOTYPING
Authors: SAWYER JR LUKACS JL MUNSHI N DESIKAN KR SINGHAL S MEHTA J SIEGEL D SHAUGHNESSY J BARLOGIE B
Citation: Jr. Sawyer et al., IDENTIFICATION OF NEW NONRANDOM TRANSLOCATIONS IN MULTIPLE-MYELOMA WITH MULTICOLOR SPECTRAL KARYOTYPING, Blood, 92(11), 1998, pp. 4269-4278
OLIGOCLONAL PROTEIN BANDS AND IG ISOTYPE SWITCHING IN MULTIPLE-MYELOMA TREATED WITH HIGH-DOSE THERAPY AND HEMATOPOIETIC-CELL TRANSPLANTATION
Authors: ZENT CS WILSON CS TRICOT G JAGANNATH S SIEGEL D DESIKAN KR MUNSHI N BRACY D BARLOGIE B BUTCH AW
Citation: Cs. Zent et al., OLIGOCLONAL PROTEIN BANDS AND IG ISOTYPE SWITCHING IN MULTIPLE-MYELOMA TREATED WITH HIGH-DOSE THERAPY AND HEMATOPOIETIC-CELL TRANSPLANTATION, Blood, 91(9), 1998, pp. 3518-3523
COLLECTION, TUMOR CONTAMINATION, AND ENGRAFTMENT KINETICS OF HIGHLY PURIFIED HEMATOPOIETIC PROGENITOR CELLS TO SUPPORT HIGH-DOSE THERAPY INMULTIPLE-MYELOMA
Authors: TRICOT G GAZITT Y LEEMHUIS T JAGANNATH S DESIKAN KR SIEGEL D FASSAS A TINDLE S NELSON J JUTTNER C TSUKAMOTO A HALLAGAN J ATKINSON K READING C HOFFMAN R BARLOGIE B
Citation: G. Tricot et al., COLLECTION, TUMOR CONTAMINATION, AND ENGRAFTMENT KINETICS OF HIGHLY PURIFIED HEMATOPOIETIC PROGENITOR CELLS TO SUPPORT HIGH-DOSE THERAPY INMULTIPLE-MYELOMA, Blood, 91(12), 1998, pp. 4489-4495
INCIDENCE AND IMPACT OF LIGHT-CHAIN ASSOCIATED (AL) AMYLOIDOSIS ON THE PROGNOSIS OF PATIENTS WITH MULTIPLE-MYELOMA TREATED WITH AUTOLOGOUS TRANSPLANTATION
Authors: DESIKAN KR DHODAPKAR MV HOUGH A WALDRON T JAGANNATH S SIEGEL D BARLOGIE B TRICOT G
Citation: Kr. Desikan et al., INCIDENCE AND IMPACT OF LIGHT-CHAIN ASSOCIATED (AL) AMYLOIDOSIS ON THE PROGNOSIS OF PATIENTS WITH MULTIPLE-MYELOMA TREATED WITH AUTOLOGOUS TRANSPLANTATION, Leukemia & lymphoma, 27(3-4), 1997, pp. 315-319
UNIQUE ROLE OF CYTOGENETICS IN THE PROGNOSIS OF PATIENTS WITH MYELOMARECEIVING HIGH-DOSE THERAPY AND AUTOTRANSPLANTS
Authors: TRICOT G SAWYER JR JAGANNATH S DESIKAN KR SIEGEL D NAUCKE S MATTOX S BRACY D MUNSHI N BARLOGIE B
Citation: G. Tricot et al., UNIQUE ROLE OF CYTOGENETICS IN THE PROGNOSIS OF PATIENTS WITH MYELOMARECEIVING HIGH-DOSE THERAPY AND AUTOTRANSPLANTS, Journal of clinical oncology, 15(7), 1997, pp. 2659-2666
FEASIBILITY AND COST-EFFECTIVENESS OF OUTPATIENT AUTOTRANSPLANTS IN MULTIPLE-MYELOMA
Authors: JAGANNATH S VESOLE DH ZHANG M DESIKAN KR COPELAND N JAGANNATH M BRACY D JONES R CROWLEY J TRICOT G BARLOGIE B
Citation: S. Jagannath et al., FEASIBILITY AND COST-EFFECTIVENESS OF OUTPATIENT AUTOTRANSPLANTS IN MULTIPLE-MYELOMA, Bone marrow transplantation, 20(6), 1997, pp. 445-450
HIGH-DOSE CHEMOTHERAPY WITH CARBOPLATIN, CYCLOPHOSPHAMIDE AND ETOPOSIDE AND AUTOLOGOUS TRANSPLANTATION FOR MULTIPLE-MYELOMA RELAPSING AFTERA PREVIOUS TRANSPLANT
Authors: MEHTA J TRICOT G JAGANNATH S DESIKAN KR SIEGEL D SINGHAL S MUNSHI N VESOLE D MATTOX S BRACY D BARLOGIE B
Citation: J. Mehta et al., HIGH-DOSE CHEMOTHERAPY WITH CARBOPLATIN, CYCLOPHOSPHAMIDE AND ETOPOSIDE AND AUTOLOGOUS TRANSPLANTATION FOR MULTIPLE-MYELOMA RELAPSING AFTERA PREVIOUS TRANSPLANT, Bone marrow transplantation, 20(2), 1997, pp. 113-116
BIOLOGY AND THERAPY OF MULTIPLE-MYELOMA IN 1996
Authors: BARLOGIE B JAGANNATH S EPSTEIN J MUNSHI N SIEGEL D DESIKAN KR FEINMAN R HSU PL VONBREMEN K TRICOT G
Citation: B. Barlogie et al., BIOLOGY AND THERAPY OF MULTIPLE-MYELOMA IN 1996, Seminars in hematology, 34(1), 1997, pp. 67-72
STEM-CELL COLLECTION IN MYELOMA PATIENTS - REPEATED ATTEMPTS MAY BE NEEDED TO OBTAIN AN ADEQUATE HARVEST IN PATIENTS FAILING TO COLLECT WELL INITIALLY
Authors: DESIKAN KR NELSON J TINDLE S SIEGEL D SINGHAL S FASSAS A TRICOT G JAGANNATH S BARLOGIE B MEHTA J
Citation: Kr. Desikan et al., STEM-CELL COLLECTION IN MYELOMA PATIENTS - REPEATED ATTEMPTS MAY BE NEEDED TO OBTAIN AN ADEQUATE HARVEST IN PATIENTS FAILING TO COLLECT WELL INITIALLY, Blood, 90(10), 1997, pp. 4208-4208
BONE-MARROW MORPHOLOGY (BMM) ADDS CRITICAL PROGNOSTIC INFORMATION TO OTHER STANDARD PARAMETERS (SP) INCLUDING CYTOGENETICS AMONG NEWLY-DIAGNOSED MULTIPLE-MYELOMA (MM) PATIENTS (PTS) RECEIVING TOTAL THERAPY (TT)
Authors: WALDRON J JAZIEH R JAGANNATH S DESIKAN KR SIEGEL D FASSAS A SINGHAL S MEHTA J TRICOT G VESOLE D WILSON C HOUGH A NAUCKE S SPOON D BARLOGIE B
Citation: J. Waldron et al., BONE-MARROW MORPHOLOGY (BMM) ADDS CRITICAL PROGNOSTIC INFORMATION TO OTHER STANDARD PARAMETERS (SP) INCLUDING CYTOGENETICS AMONG NEWLY-DIAGNOSED MULTIPLE-MYELOMA (MM) PATIENTS (PTS) RECEIVING TOTAL THERAPY (TT), Blood, 90(10), 1997, pp. 394-394
PROLONGED IMMUNOSUPPRESSION AFTER CD34(+) OR CD34(+) THY-1(+)/LIN(ASTERISK) SELECTED AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTS (TX) FOR MULTIPLE-MYELOMA/
Authors: SIEGEL D MEHTA J ANAISSIE E DESIKAN KR FASSAS A JAGANNATH S SINGHAL S TRICOT G MUNSHI N BARNHART S HOOD S SPOON D MATTOX S BARLOGIE B
Citation: D. Siegel et al., PROLONGED IMMUNOSUPPRESSION AFTER CD34(+) OR CD34(+) THY-1(+)/LIN(ASTERISK) SELECTED AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTS (TX) FOR MULTIPLE-MYELOMA/, Blood, 90(10), 1997, pp. 487-487
SUPERIOR OUTCOME WITH MELPHALAN-200 MG M(3) (MEL200) FOR SCHEDULED 2ND-AUTOTRANSPLANT COMPARED MEL+TBI OR CTX FOR MYELOMA (MM) IN PRE-TX-2 PR/
Authors: DESIKAN KR FASSAS A SIEGEL D JAGANNATH S MEHTA J SINGHAL S BRACY D TRICOT G BARLOGIE B
Citation: Kr. Desikan et al., SUPERIOR OUTCOME WITH MELPHALAN-200 MG M(3) (MEL200) FOR SCHEDULED 2ND-AUTOTRANSPLANT COMPARED MEL+TBI OR CTX FOR MYELOMA (MM) IN PRE-TX-2 PR/, Blood, 90(10), 1997, pp. 1016-1016
PERIPHERAL-BLOOD STEM-CELL (PBSC) COLLECTION WITH G-CSF ALONE IN MULTIPLE-MYELOMA (MM) - FACTORS ASSOCIATED WITH POST TRANSPLANT (TX) RECOVERY
Authors: DESIKAN KR MEHTA J FASSAS A SIEGEL D MUNSHI N SINGHAL S JAGANNATH S TRICOT G BARLOGIE B
Citation: Kr. Desikan et al., PERIPHERAL-BLOOD STEM-CELL (PBSC) COLLECTION WITH G-CSF ALONE IN MULTIPLE-MYELOMA (MM) - FACTORS ASSOCIATED WITH POST TRANSPLANT (TX) RECOVERY, Blood, 90(10), 1997, pp. 1017-1017
AUTOPSY REVIEW IN MULTIPLE-MYELOMA (MM) REVEALS ASPERGILLOSIS (ASP) AS A SIGNIFICANT CAUSE OF DEATH AFTER HIGH-DOSE THERAPY (HDT) ESPECIALLY WITH ALLOTRANSPLANTS (ALLO-TX)
Authors: KONERU B HOUGH A FASSAS A TRICOT G DESIKAN KR SIEGEL D JAGANNATH S SINGHAL S MEHTA J BARLOGIE B ANAISSIE E
Citation: B. Koneru et al., AUTOPSY REVIEW IN MULTIPLE-MYELOMA (MM) REVEALS ASPERGILLOSIS (ASP) AS A SIGNIFICANT CAUSE OF DEATH AFTER HIGH-DOSE THERAPY (HDT) ESPECIALLY WITH ALLOTRANSPLANTS (ALLO-TX), Blood, 90(10), 1997, pp. 1573-1573
FINAL ANALYSIS OF TOTAL THERAPY (TT) WITH TANDEM TRANSPLANTS (TX) FOR231 NEWLY-DIAGNOSED PATIENTS (PTS) WITH MULTIPLE-MYELOMA (MM)
Authors: JAGANNATH S VESOLE D SIEGEL D DESIKAN KR MUNSHI N FASSAS A SINGHAL S MEHTA J SPOON D TRICOT G EVANS T NAUCKE S TINDLE S NELSON J COPELAND N BARLOGIE B
Citation: S. Jagannath et al., FINAL ANALYSIS OF TOTAL THERAPY (TT) WITH TANDEM TRANSPLANTS (TX) FOR231 NEWLY-DIAGNOSED PATIENTS (PTS) WITH MULTIPLE-MYELOMA (MM), Blood, 90(10), 1997, pp. 1860-1860
SIMILAR PROGNOSIS AFTER TANDEM AUTOTRANSPLANTS (TAT) FOR MYELOMA LESS-THAN-65 YR AND GREATER-THAN-OR-EQUAL-TO-65 YR
Authors: SIEGEL D JAGANNATH S DESIKAN KR TRICOT G VESOLE D FASSAS A SINGHAL S MEHTA J HOOD S BARLOGIE B
Citation: D. Siegel et al., SIMILAR PROGNOSIS AFTER TANDEM AUTOTRANSPLANTS (TAT) FOR MYELOMA LESS-THAN-65 YR AND GREATER-THAN-OR-EQUAL-TO-65 YR, Blood, 90(10), 1997, pp. 1861-1861
TUMOR LYSIS SYNDROME (TLS) FOLLOWING INTERMEDIATE AND HIGH-DOSE THERAPY IN PATIENTS (PTS) WITH MULTIPLE-MYELOMA (MM) - ASSOCIATION WITH HIGH TUMOR MASS, IMMATURE MORPHOLOGY, HIGH LABELING INDEX (LI) AND ABNORMAL CYTOGENETICS (CG)
Authors: FASSAS A DESIKAN KR GOLPER T SIEGEL D SINGHAL S MEHTA J MATTOX S JAGANNATH S TRICOT G BARLOGIE B
Citation: A. Fassas et al., TUMOR LYSIS SYNDROME (TLS) FOLLOWING INTERMEDIATE AND HIGH-DOSE THERAPY IN PATIENTS (PTS) WITH MULTIPLE-MYELOMA (MM) - ASSOCIATION WITH HIGH TUMOR MASS, IMMATURE MORPHOLOGY, HIGH LABELING INDEX (LI) AND ABNORMAL CYTOGENETICS (CG), Blood, 90(10), 1997, pp. 2347-2347
HEMATOPOIETIC STEM-CELL TRANSPLANTS FOR MULTIPLE-MYELOMA
Authors: TRICOT G JAGANNATH S VESOLE DH BRACY D DESIKAN KR SIEGEL D BARLOGIE B
Citation: G. Tricot et al., HEMATOPOIETIC STEM-CELL TRANSPLANTS FOR MULTIPLE-MYELOMA, Leukemia & lymphoma, 22(1-2), 1996, pp. 25-36
AUTOLOGOUS BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATIONIN MULTIPLE-MYELOMA
Authors: VESOLE DH JAGANNATH S TRICOT G DESIKAN KR SIEGEL D BARLOGIE B
Citation: Dh. Vesole et al., AUTOLOGOUS BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATIONIN MULTIPLE-MYELOMA, Cancer investigation, 14(4), 1996, pp. 378-391
AUTOTRANSPLANTS IN MULTIPLE-MYELOMA - WHAT HAVE WE LEARNED
Authors: VESOLE DH TRICOT G JAGANNATH S DESIKAN KR SIEGEL D BRACY D MILLER L CHESON B CROWLEY J BARLOGIE B
Citation: Dh. Vesole et al., AUTOTRANSPLANTS IN MULTIPLE-MYELOMA - WHAT HAVE WE LEARNED, Blood, 88(3), 1996, pp. 838-847
Risultati: 1-25 | 26-46